tradingkey.logo
tradingkey.logo
Search

Fibrobiologics Inc

FBLG
Add to Watchlist
0.700USD
-0.019-2.67%
Close 07-31 16:00ETQuotes delayed by 15 min
2.46MMarket Cap
LossP/E TTM

FBLG Financials

See Fibrobiologics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Fibrobiologics Inc Earnings Date

Latest Release
Apr 30, 2026
EPS / Forecast
-1.33/-1.30
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-8.35
-22.98%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Financial Indicators
EPS
-444.42%-0.66
-878.68%-1.33
-1087.31%-1.08
-799.13%-0.13
-539.20%-0.12
50.17%-0.14
85.52%-0.09
77.89%-0.01
141.25%0.03
-76.93%-0.27
-1236.54%-0.63
---0.07
---0.07
---0.15
---0.05
---0.11
Net Profit
11.61%-4.12M
-0.68%-5.00M
-4.68%-3.24M
-1055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
68.11%-3.10M
77.19%-500.00K
141.55%898.00K
-69.61%-8.46M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---4.99M
---1.52M
---1.56M
Debt to assets ratio
-97.30%1.56%
-91.89%4.14%
-100.00%0.00%
4661.05%52.30%
1701.02%58.00%
1169.11%51.10%
4573.87%55.75%
3.61%1.10%
--3.22%
--4.03%
--1.19%
--1.06%
--0.00%
----
----
----
Operating profit
10.18%-4.03M
-11.85%-5.07M
30.23%-2.59M
-50.30%-5.04M
-39.27%-4.49M
-31.33%-4.53M
-49.68%-3.71M
-63.43%-3.35M
-54.04%-3.22M
-52.32%-3.45M
-90.18%-2.48M
-52.95%-2.05M
---2.09M
---2.27M
---1.30M
---1.34M
Net Profit
11.61%-4.12M
-0.68%-5.00M
-4.68%-3.24M
-1055.60%-5.78M
-618.71%-4.66M
41.30%-4.97M
68.11%-3.10M
77.19%-500.00K
141.55%898.00K
-69.61%-8.46M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---4.99M
---1.52M
---1.56M
Current assets
-42.52%5.85M
-68.85%2.90M
-55.38%6.35M
-36.08%5.24M
56.37%10.18M
4.54%9.33M
54.40%14.23M
-24.89%8.20M
-44.65%6.51M
--8.92M
--9.21M
--10.91M
--11.76M
----
----
----
Total current liabilities
-79.82%2.21M
-77.73%1.83M
-86.18%1.76M
0.67%6.72M
8.21%10.96M
-41.29%8.21M
38.58%12.73M
408.14%6.68M
975.58%10.13M
--13.98M
--9.18M
--1.31M
--942.00K
----
----
----
Total assets
-42.99%7.93M
-48.03%5.94M
-41.51%9.62M
-16.48%8.74M
56.05%13.91M
0.24%11.43M
39.12%16.45M
-21.28%10.47M
-35.63%8.91M
--11.40M
--11.82M
--13.30M
--13.84M
----
----
----
Total liabilities
-74.76%3.29M
-63.22%3.34M
-74.74%3.46M
11.47%8.62M
15.47%13.05M
-40.53%9.08M
29.73%13.71M
180.04%7.73M
353.59%11.30M
--15.26M
--10.57M
--2.76M
--2.49M
----
----
----
Total equity
439.07%4.64M
10.64%2.60M
125.08%6.16M
-95.43%125.00K
136.03%860.00K
160.83%2.35M
118.28%2.73M
-74.03%2.74M
-121.03%-2.39M
---3.86M
--1.25M
--10.54M
--11.35M
----
----
----
Net operating income
17.39%-3.29M
17.27%-4.36M
-2.93%-3.16M
-52.42%-3.97M
-104.62%-3.98M
-23.39%-5.28M
-91.94%-3.07M
-128.80%-2.61M
-19.82%-1.95M
-109.97%-4.28M
-36.49%-1.60M
16.68%-1.14M
---1.63M
---2.04M
---1.17M
---1.37M
Net investment
100.00%0.00
100.00%0.00
100.00%0.00
45.45%-6.00K
-222.73%-213.00K
-437.50%-43.00K
-4850.00%-99.00K
97.34%-11.00K
-175.00%-66.00K
85.71%-8.00K
---2.00K
---413.00K
---24.00K
---56.00K
----
--0.00
Net financing
21.69%5.32M
--952.00K
-65.81%3.19M
-100.00%0.00
2643.60%4.38M
-100.00%0.00
--9.33M
375.64%4.47M
89.96%-172.00K
-77.50%3.28M
-100.00%0.00
413.33%940.00K
---1.71M
--14.57M
--2.15M
---300.00K

FAQs

What are the current assets of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its current assets were 6.35M, with a year-on-year change of -55.38.

What are the total assets of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its total assets of Fibrobiologics Inc were 9.62M, with a year-on-year change of -41.51.

What are the total liabilities of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its total liabilities of Fibrobiologics Inc were 3.46M, with a year-on-year change of -74.74.

What is the total equity of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its total equity of Fibrobiologics Inc was 6.16M, with a year-on-year change of 125.08.

What is the net operating income of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its net operating income of Fibrobiologics Inc was -16.65M, with a year-on-year change of -21.20.

What is the net investment of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its net investment of Fibrobiologics Inc was -262.00K, with a year-on-year change of -42.39.

What is the net financing of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its net financing of Fibrobiologics Inc was 7.57M, with a year-on-year change of -55.26.

What is the Earnings Per Share (EPS) of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.35, with a year-on-year change of -22.98.

What is the net income of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its net income was -18.65M, with a year-on-year change of -67.06.

What is the Return on Equity (ROE) of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its Return on Equity (ROE) was -419.44, with a year-on-year change of 25.06.

What is the Return on Assets (ROA) of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its Return on Assets (ROA) was -143.08, with a year-on-year change of -81.18.

What is the operating profit of Fibrobiologics Inc?

According to Fibrobiologics Inc's FY2025 earnings report, its operating profit was -16.65M, with a year-on-year change of -21.20.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.